Role of individualized intervention(s) on quality of life (QoL) and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer (bc): MyChoice study
Shahid Ahmed(Emory University), Anne Leis(Saskatchewan Health Authority), Saija Kontulainen(University of Saskatchewan), D. Bulych(Saskatchewan Cancer Agency), Muhammad Farooq Khan(King Saud University), Tooba Asif(University of Saskatchewan), Haji Chalchal, Osama Ahmed(University of Saskatchewan), Lynn Dwernychuk(Saskatchewan Cancer Agency), Muhammad Salim(Saskatchewan Cancer Agency), Nayyer Iqbal(University of Saskatchewan), D. Gowan-Moody(University of Saskatchewan), June Lim(University of Saskatchewan), Amer Sami(University of Saskatchewan)
Cited by 0
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
Complementary and alternative medicine whole systems research: Beyond identification of inadequacies of the RCT
|Complementary Therapies in Medicine|2005|272
Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
|Journal of Clinical Oncology|2013|261